In the News

Read the latest about us

Interviewing the Swedish Biotech that started the first Phase II Trial in Bahrain

I was curious to interview Christina Herder, the CEO of Modus Therapeutics, which launched a Phase II trial in co-operation with Bahrain and the rest of the Emirates.

Innovative Bahraini Deal Inked For Sickle Cell Therapy

Modus Therapeutics AB announced Feb. 16, the Middle East University has shouldered some of the risk of developing sevuparin.